American Association of Homeopathic Pharmacists
5112 Wilshire Drive
Santa Rosa, CA 95404
Eric L. Foxman, Secretary
FOR IMMEDIATE RELEASE
April 2, 2007
AAHP donates $35K to HPUS, initiating a new phase in funding efforts
The Homeopathic Pharmacopoeia of the United States (HPUS) has stood as the cornerstone of homeopathic product identity and quality for over 110 years. The work of the Homeopathic Pharmacopoeia is conducted by the Homeopathic Pharmacopeial Convention of the United States (HPCUS). This almost exclusively volunteer organization is made up of medical and scientific professionals. The HPCUS supports the research, standards and requirements which ensure the legality, safety and efficacy of homeopathic drugs manufactured and marketed in the United States. The Homeopathic Pharmacopoeia as an official compendium to the Food Drug and Cosmetic Act is an essential component of the regulatory framework which provides for stability, growth and investment in the homeopathic drug market.
To continue this vital work and help ensure adequate funding for future HPCUS projects the American Association of Homeopathic Pharmacists (AAHP) and its member companies have donated $35,000 to HPCUS. The donation was made at the HPCUS annual meeting held March 25 th in Baltimore Maryland. The contribution was presented by Mark Land, president of the American Association of Homeopathic Pharmacists to John A. Borneman III, president of HPCUS and represents the combined contributions of 24 AAHP member pharmacists and companies.
This is not the first time that a major gift has been provided to the HPCUS, a 501(c)(3) foundation, to support its work but does represent a new phase in funding efforts. A more visible profile for the HPCUS will focus on gathering additional financial support and contributions from organizations which are interested in the continued growth of complementary and alternative medical practices. Contributions will be used to fund new projects in the areas of quality, toxicology and industry concerns. "The contributions made by the HPCUS volunteers and financial supporters helps to ensure the market viability of an entire class of drug products that are of value to American consumers and health practitioners" says Mark Land. "The AAHP, along with other industry leaders see this as a vital opportunity for greater cooperation and support of the scientific, legal and regulatory foundation of our industry."